Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Light skin shows more inflammation from sun exposure than dark skin.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

EPI-NCSCs from hair follicles may help treat brain development issues in mice.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Inflammation damages sweat ducts, causing sweat gland injury.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Targeting Vδ1+T-cells may help treat alopecia areata.

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Plucked hair follicles can help diagnose scalp lupus.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Melatonin improves cashmere goat hair quality by increasing follicles and reducing skin aging.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Low oxygen areas help maintain and protect blood stem cells by using a simple sugar breakdown process for energy and managing their activity levels.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.